Parkinson's disease (PD) is neuropathologically characterized as an alpha‐
synucleinopathy. Alpha‐synuclein‐containing inclusions are stained as L ewy bodies and L …

Parkinson's disease (PD) is a neurodegenerative disorder whose aetiology remains unclear:
degeneration involves several neurotransmission systems, resulting in a heterogeneous …

Importance Alterations in cerebrospinal fluid (CSF) have been found in Parkinson disease
(PD) and in PD dementia (PDD), but the prognostic importance of such changes is not well …

Parkinson's disease (PD) is the second most common progressive neurodegenerative
disorder and is characterized by loss of dopaminergic neurons. Biomarkers for tracking …

Artificial, de-novo manufactured materials (with controlled nano-sized characteristics) have
been progressively used by neuroscientists during the last several decades. The …

Abstract Background Predicting prognosis in Parkinson's disease (PD) has important
implications for individual prognostication and clinical trials design and targeting novel …

Background: Parkinson's disease (PD) is a progressive, multi-focal neurodegenerative
disease for which there is no effective disease modifying treatment. A critical requirement for …

Background: QEEG could provide physiological biomarkers for changes over time in
Parkinson's disease (PD) cognitive decline if they track with longitudinal neuropsychological …

A new computational approach may provide improved detection of disease conditions and
comorbidities, such as PTSD, Parkinson's, Alzheimer's, depression, etc. For example, in an …

Background Parkinson's disease (PD) is a progressive neurodegenerative disorder causing
motor and non-motor symptoms that can affect independence, social adjustment and the …